Şeyda Örs Kaya

Şeyda Örs Kaya

Auto-generated profile, based on publicly available information

Şeyda Örs Kaya

University of Health Sciences Turkey, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Annals of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
OSOzgur Samancilar
Ozgur Samancilar
TATevfik İlKer Akçam
Tevfik İlKer Akçam
SKSeyda Ors Kaya
Seyda Ors Kaya
OOOzgur Ozturk
Ozgur Ozturk
OAOnur Akçay
Onur Akçay
KCKenan Can Ceylan
Kenan Can Ceylan
Background: Development of multiloculation–septation is a challenging entity in empyema patients. In this study, it is aimed to investigate the success rates of videothoracoscopic deloculation (VATS-D) and intrapleural fibrinolytic (IPFib) application after tube thoracostomy.Methods: The study retrospectively examined the patients diagnosed with empyema with multiloculation and septation between January 2005 and December 2014. Among these patients, the study included those who received VATS-D or IPFib therapy.Results: VATS-D (Group 1) was applied to 54 patients and IPFib (Group 2) was applied to 24 patients. The success of both procedures was evaluated considering the need of decortication in the following periods. In the VATS-D group, 4 (7.4%) patients required decortication via thoracotomy where it was 1 (4.1%) patient (p = 0.577) in the IPFib group. The length of hospital stay was 6.81 ± 2.55 (4–15) days in Group 1 compared to 14.25 ± 6.44 (7–27) days in Group 2 (p <0.001).Conclusions: It was demonstrated that both of the methods applied in the study have high efficacy and are preferable methods based on the general conditions of patients. Additionally, the shorter length of hospital stays in patients received VATS-D was established as a significant parameter.

17 September 2019 in Balkan Medical Journal
Verified
Journal Article
Open access
DYDemet Yaldız
Demet Yaldız
ŞKŞeyda Örs Kaya
Şeyda Örs Kaya
KCKenan Can Ceylan
Kenan Can Ceylan
AAArkın Acar
Arkın Acar
ZAZekiye Aydoğdu
Zekiye Aydoğdu
SYSadık Yaldız
Sadık Yaldız
Predominant histologic subtypes have been reported as predictors of survival of patients with pulmonary adenocarcinoma. To evaluate the predictive value of histologic classification in resected lung adenocarcinoma using the classification systems proposed by the International Association for the Study of Lung Cancer, American Thoracic Society, European Respiratory Society, and World Health Organization (2015). Cross-sectional study. The histologic classification of a large cohort of 491 patients with resected lung adenocarcinoma (stages I-III) was retrospectively analyzed. The tumors were classified according to their predominant component (lepidic, acinar, papillary, solid, micropapillary, and mucinous), and their predictive values were assessed for clinicopathologic characteristics and overall survival. The patient cohort comprised 158 (32.2%) patients with solid predominant, 150 (30.5%) with acinar predominant, 80 (16.3%) with papillary predominant, 75 (15.3%) with lepidic predominant, 22 (4.5%) with mucinous, and 5 (1.0%) with micropapillary subtype, and 1 (0.2%) with adenocarcinoma in situ. Overall 5-year survival of 491 patients was found to be 51.8%. Patients with lepidic, acinar, and mucinous adenocarcinoma had 70.9%, 59.0%, and 66.6% 5-year survival, respectively, and there was no statistically significant difference between them. Whereas patients with solid, papillary, and micropapillary predominant adenocarcinoma had 41.0%, 40.5%, and 0.0% 5-year survival, respectively. Compared to other histologic subtypes, patients with solid and papillary predominant adenocarcinoma had significantly lower survival than those with lepidic (p<0.001, p=0.002), acinar (p<0.001, p=0.008), and mucinous (p=0.048, p=0.048) subtypes, respectively. The survival difference between patients with solid subtype and those with papillary subtype was not statistically significant (p=0.67). Solid and papillary histologic subtypes are poor prognostic factors in resected invasive lung adenocarcinoma.

3 May 2024 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
GBGüntug Batıhan
Güntug Batıhan
KCKenan Can Ceylan
Kenan Can Ceylan
ŞKŞeyda Örs Kaya
Şeyda Örs Kaya
Background: Although pneumonectomy has relatively high mortality and morbidity rates, it remains valid in the surgical treatment of lung cancer. This study aims to evaluate the prognostic significance of postoperative complications after pneumonectomy and demonstrate the risk factors related to early postoperative complications. Methods: Patients who underwent pneumonectomy for non-small cell lung cancer between January 2008 and May 2021 were included in the study. Factors related to the development of early postoperative complications and overall survival were evaluated by univariate and multivariate analyses. Results: A total of 136 patients were included in the study. Early postoperative complications were seen in 33 (24.3%) patients and late postoperative complications in 7 (5.1%) patients. The amount of cigarette smoking, and the operation side were the independent variables that affect the development of early postoperative complications. In multivariate analysis, smoking amount and pericardial invasion were associated with the development of postoperative hemorrhage, and advanced age was associated with the development of postoperative pneumonia. Conclusions: Early postoperative complications have a negative effect on the prognosis after pneumonectomy therefore careful patient selection and preoperative risk assessment are essential to minimize the occurrence of complications and improve patient outcomes. Trial registration: This observational study was approved by the (Ethical Committee of Dr. Suat Seren Chest Diseases and Chest Surgery Education and Research Center) Institutional Review Board of our center (E-49109414-604.02.02-218625439).

25 February 2023 in Updates in Surgery
Verified
Journal Article
Closed access
PDF file
GBGüntug Batıhan
Güntug Batıhan
KCKenan Can Ceylan
Kenan Can Ceylan
AÜAhmet Üçvet
Ahmet Üçvet
ŞKŞeyda Örs Kaya
Şeyda Örs Kaya
SYSerkan Yazgan
Serkan Yazgan

1 October 2006 in Chest
Verified
Journal Article
Open access
SBSevin Baser
Sevin Baser
FEFatma Evyapan
Fatma Evyapan
SKSeyda Kaya
Seyda Kaya
FBFerda Bir
Ferda Bir
GKGoksel Kiter
Goksel Kiter
VCVeli Cobankara
Veli Cobankara
INTRODUCTION: Pneumonia, cancer, tuberculosis, and pulmonary embolism account for most exudative effusions. Rhematoid pleuritis usually occurs during the course of previously diagnosed rheumatoid arthritis. Occasionally, it may be first manifestation of the disease. CASE PRESENTATION: A 22-year-old man was admitted to our hospital because of persistent bilateral pleural effusions and new onset of fever. He had been diagnosed with tuberculosis pleurisy in another hospital (all ARB smears were negative from pleural effusion at that time) 2 months ago and had been receiving anti-tbc drug therapy since than. He has begun to experience fever, general malaise and chest pain aggravated by cough for 3 days. Thoracentesis was performed. Cytologic examination of pleural fluid revealed no malignant cells. Given an effusion with predominance of neutrophils and high lactade dehydrogenase level, empyema was suspected and the patient was treated accordingly antibiotics. Microbiologic studies including smears and cultures of pleural fluid showed no yields. Meantime a rash occurred over his body. Pleural biopsy though video-assisted thoracoscopic surgery (VATS) was performed and demonstrated the characteristic histopathologic findings of Still‘s disease. Methylprednisolone, methotrexate, and other immunosuppressives were started. His fever disappeared and pleural effusion regressed. DISCUSSIONS: Although pleural effusion is the most common intrathoracic complication of rheumatoid arthritis, it occurs only 2 to 3 % of patients. Occasionally, it may be the first manifestation or coincide with the onset of the disease. Adult onset of Still‘s disease (juvenile rheumatoid arthritis with septic appearance) is rare, leading to clinical signs similar to those seen in bacterial sepsis, lymphomas, or systemic autoimmune diseases. This disease can present with fever and can cause difficulties in the diagnosis. Rheumatoid pleural effusion is described as an exudate with low values of glucose and pH and high LDH activity. However, this biochemical constellation is suggestive but not specific of rheumatoid pleuritis, it can be found in the effusions caused by malignancy, complicated parapneumonic effusions, empyema, and tuberculosis. Accordingly, a high index of suspicion is of clinical importance in making a diagnosis. The diagnosis is based upon the evaluation of clinical signs and laboratorical data together. Prolonged immunosuppressive therapy is required. CONCLUSION: This case illustrates that rheumatoid pleuritis should be suspected in a patient with exudative pleural effusion who doesn't respond to antibiotics. A high index of suspicion is of clinical importance in making a diagnosis. DISCLOSURE: Sevin Baser, None.

1 January 2024 in Turkish Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
OUOzan Usluer
Ozan Usluer
ÖGÖzde Elif Gökbayrak
Özde Elif Gökbayrak
AEAylin Erol
Aylin Erol
TATekincan Aktaş
Tekincan Aktaş
GBGüntug Batıhan
Güntug Batıhan
SASafiye Aktaş
Safiye Aktaş
Background: In this study, we aimed to investigate the prognostic value of programmed cell death protein 1 (PD-1), programmed cell death ligand 1 (PD-L1), and programmed cell death ligand 2 (PD-L2) expressions on immune and cancer cells in terms of survival in patients with lung adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Methods: Between January 2000 and December 2012, a total of 191 patients (172 males, 19 females; mean age: 60.3±8.4 years; range, 38 to 78 years) who were diagnosed with non-small cell lung cancer and underwent anatomic resection and mediastinal lymph node dissection were retrospectively analyzed. The patients were evaluated in three groups including lung squamous cell carcinoma (n=61), adenocarcinoma (n=66), and large-cell carcinoma (n=64). The survival rates of all three groups were compared in terms of immunohistochemical expression levels of PD-1, PD-L1, and PD-L2. Results: The mean follow-up was 71.8±47.9 months. In all histological subtypes, PD-1 expressions on tumor and immune cells were observed in 33% (61/191) and in 53.1% (102/191) of the patients, respectively. Higher expression levels of PD-L1 and PD-L2 at any intensity on tumor and immune cells were defined only in lung adenocarcinomas, and PD-L1 and PD-L2 values were detected in 36.4% (22/64) of these patients. The PD-L1 expressions on tumor and immune cells were observed in 41.7% (10/24) and 25% (6/24) of the patients, respectively. The PD-L2 expressions on tumor and immune cells were detected in 16.7% (4/24) and 8.4% (2/24) of the patients, respectively. Univariate and multivariate analyses revealed that PD-1 expression in tumor cells was an independent prognostic factor in all histological subtypes. Conclusion: Our study results suggest that PD-1 expression is a poor prognostic factor for overall survival in patients with completely resected adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.